Viking Therapeutics VKTX
NASDAQ VKTX
$25.83 -0.55 (-2.08%)
At close: Oct 22, 2026 · 4:00 PM EDT

Viking Therapeutics (VKTX) Times Interest Earned (2014 - 2015)

Updated

Viking Therapeutics' (VKTX) Times Interest Earned stood at -13.08 in Q1 2015, compared with -81.42 a year earlier.

Analysis

Viking Therapeutics (VKTX) Times Interest Earned (2014 - 2015) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Times Interest Earned (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn -
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 28.50
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn -
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 10.28
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 7.27
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 5.22
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -42.08
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn -
10 Viking Therapeutics 2.99 Bn 464.96 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2015 -13.08
Mar 31, 2014 -81.42
API Access

Viking Therapeutics Times Interest Earned API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=times-interest-earned&ticker=VKTX&period=max&api_key=YOUR_API_KEY